$SMR

Why NuScale Power Stock Fell 29% in the First Half of 2026

NuScale Power shares fell 29.2% in the first half of 2026, according to S&P Global Market Intelligence. The article cites concerns about potential delays to NuScale’s Romania project, a $507.4 million milestone payment to ENTRA1 Energy, rising operating loss to $690 million, and Q1 revenue dropping to $0.5 million. It also notes Fluor exited NuScale by April 2026.

Original reporting
Published Jul 23, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 9:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why NuScale Power Stock Fell 29% in the First Half of 2026 — source image
Decision brief

The 30-second read

$SMRBearishMed
01

Why it matters

The article links the stock’s sharp decline to (1) potential Romania timeline slippage to 2034, (2) a large ENTRA1 milestone payment tied to development fees without guaranteed revenues, and (3) worsening operating losses and revenue collapse in Q1, despite sizable cash reserves.

02

Market read

Traders get a consolidated catalyst stack explaining the drawdown: execution delays, partner contract cash outflows, and deteriorating operating metrics.

03

What to watch

The article emphasizes delays and partner fees but does not quantify contract milestones, probability-weighted timelines, or potential upside from TVA-related deployment progress.

Relevance 7/10Novelty 6/10Timing: post-market analysis tied to H1 2026 performance and recent Q4/Q1 disclosures

Background

NuScale is an SMR developer whose design is NRC-approved, but the company has not yet built a reactor; commercialization depends on module delivery and partner arrangements.

Company-level read

Ticker impact

$SMRBearishHigh confidence
Context

Article attributes SMR’s 29.2% H1 2026 decline to a Romania project delay risk, a $507.4M ENTRA1 milestone payment, and widening losses.

Expected impact

Near-term downside bias until commercialization milestones and partner economics de-risk; volatility likely elevated.

Evidence & confidence

The text cites specific, company-linked catalysts: analyst warning on Romania timing, a large milestone payment to ENTRA1 without guaranteed revenues, and sharply higher operating losses plus revenue collapse in Q1.

Market effects

Highlights financing and execution risk for SMR developers, especially where commercialization partners receive milestone/fee economics without guaranteed revenue.

Romania project delay risk reinforces uncertainty for European SMR deployment timelines.

US policy support for nuclear capacity does not offset company-specific execution and partner-contract risk.

Counterpoint

SMR has $890M cash and short-term investments with zero long-term debt, so the selloff may over-discount eventual module delivery and government-backed demand.

Key entities

  • NuScale Power

    SMR developer whose shares fell 29.2% in H1 2026 amid delays, partner-payment economics, and rising losses.

  • ENTRA1 Energy

    Exclusive commercialization partner referenced in the $507.4M milestone payment and fee structure without guaranteed revenues.

  • Fluor

    Largest shareholder that exited NuScale by April 2026 after selling its position.

  • TD Cowen (Marc Bianchi)

    Raised alarm about Romania flagship project potentially delayed until 2034.

  • TVA

    Referenced for an agreement to deploy up to 6 GW using NuScale SMR equipment, but lacking a finalized timeline and long-term PPA in the article.

Related articles

$STLAMed

Why Did STLA, OLLI, SMR Stocks Hit 52-Week Lows Today?

Stellantis (STLA), Ollie’s Bargain Outlet (OLLI) and NuScale Power (SMR) hit fresh 52-week lows amid worries about slower growth, higher costs and uncertain timelines. STLA fell to $5.33 after a JPMorgan downgrade to Neutral and a cut to a $6.85 target. OLLI slid to $61.61 after JPMorgan cut its target to $70. SMR touched $8.55 after a larger-than-expected Q1 loss and revenue decline.

$SMRLow

NUSCALE POWER Corp (SMR): Results of Operations and Financial Condition

NUSCALE POWER Corp (SMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. smr-20260805 0001822966 FALSE 0001822966 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 8-K __________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES E

$XEMed

XE Vs SMR: Analysts See One Small Nuclear Stock With Nearly Double The Upside

Analysts highlighted X-Energy (XE) versus NuScale Power (SMR) as small modular nuclear plays amid rising power demand. X-Energy joined the DOE Genesis Mission’s Prometheus initiative, investing $10M and contributing its Xe-100 reactor and TRISO-X fuel. Koyfin data show XE avg 12-month target $37.86 versus SMR $14.57. Barclays cut SMR to $11; Citi raised to $7.50.